Cargando…

Obstetric Management of COVID-19 in Pregnant Women

The 2019 novel coronavirus disease (COVID-19), which is caused by the novel beta coronavirus, SARS-CoV-2, is currently prevalent all over the world, causing thousands of deaths with relatively high virulence. Like two other notable beta coronaviruses, severe acute respiratory syndrome coronavirus-1...

Descripción completa

Detalles Bibliográficos
Autores principales: Mei, Youwen, Luo, Dan, Wei, Sumei, Liao, Xiaoyan, Pan, Yue, Yang, Xiao, Lin, Yonghong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7264107/
https://www.ncbi.nlm.nih.gov/pubmed/32574255
http://dx.doi.org/10.3389/fmicb.2020.01186
_version_ 1783540902883491840
author Mei, Youwen
Luo, Dan
Wei, Sumei
Liao, Xiaoyan
Pan, Yue
Yang, Xiao
Lin, Yonghong
author_facet Mei, Youwen
Luo, Dan
Wei, Sumei
Liao, Xiaoyan
Pan, Yue
Yang, Xiao
Lin, Yonghong
author_sort Mei, Youwen
collection PubMed
description The 2019 novel coronavirus disease (COVID-19), which is caused by the novel beta coronavirus, SARS-CoV-2, is currently prevalent all over the world, causing thousands of deaths with relatively high virulence. Like two other notable beta coronaviruses, severe acute respiratory syndrome coronavirus-1 (SARS-CoV-1) and Middle East respiratory syndrome coronavirus (MERS-CoV), SARS-CoV-2 can lead to severe contagious respiratory disease. Due to impaired cellular immunity and physiological changes, pregnant women are susceptible to respiratory disease and are more likely to develop severe pneumonia. Given the prevalence of COVID-19, it is speculated that some pregnant women have already been infected. However, limited data are available for the clinical course and management of COVID-19 in pregnancy. Therefore, we conducted this review to identify strategies for the obstetric management of COVID-19. We compared the clinical course and outcomes of COVID-19, SARS, and MERS in pregnancy and discussed several drugs for the treatment of COVID-19 in pregnancy.
format Online
Article
Text
id pubmed-7264107
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-72641072020-06-10 Obstetric Management of COVID-19 in Pregnant Women Mei, Youwen Luo, Dan Wei, Sumei Liao, Xiaoyan Pan, Yue Yang, Xiao Lin, Yonghong Front Microbiol Microbiology The 2019 novel coronavirus disease (COVID-19), which is caused by the novel beta coronavirus, SARS-CoV-2, is currently prevalent all over the world, causing thousands of deaths with relatively high virulence. Like two other notable beta coronaviruses, severe acute respiratory syndrome coronavirus-1 (SARS-CoV-1) and Middle East respiratory syndrome coronavirus (MERS-CoV), SARS-CoV-2 can lead to severe contagious respiratory disease. Due to impaired cellular immunity and physiological changes, pregnant women are susceptible to respiratory disease and are more likely to develop severe pneumonia. Given the prevalence of COVID-19, it is speculated that some pregnant women have already been infected. However, limited data are available for the clinical course and management of COVID-19 in pregnancy. Therefore, we conducted this review to identify strategies for the obstetric management of COVID-19. We compared the clinical course and outcomes of COVID-19, SARS, and MERS in pregnancy and discussed several drugs for the treatment of COVID-19 in pregnancy. Frontiers Media S.A. 2020-05-26 /pmc/articles/PMC7264107/ /pubmed/32574255 http://dx.doi.org/10.3389/fmicb.2020.01186 Text en Copyright © 2020 Mei, Luo, Wei, Liao, Pan, Yang and Lin. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Microbiology
Mei, Youwen
Luo, Dan
Wei, Sumei
Liao, Xiaoyan
Pan, Yue
Yang, Xiao
Lin, Yonghong
Obstetric Management of COVID-19 in Pregnant Women
title Obstetric Management of COVID-19 in Pregnant Women
title_full Obstetric Management of COVID-19 in Pregnant Women
title_fullStr Obstetric Management of COVID-19 in Pregnant Women
title_full_unstemmed Obstetric Management of COVID-19 in Pregnant Women
title_short Obstetric Management of COVID-19 in Pregnant Women
title_sort obstetric management of covid-19 in pregnant women
topic Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7264107/
https://www.ncbi.nlm.nih.gov/pubmed/32574255
http://dx.doi.org/10.3389/fmicb.2020.01186
work_keys_str_mv AT meiyouwen obstetricmanagementofcovid19inpregnantwomen
AT luodan obstetricmanagementofcovid19inpregnantwomen
AT weisumei obstetricmanagementofcovid19inpregnantwomen
AT liaoxiaoyan obstetricmanagementofcovid19inpregnantwomen
AT panyue obstetricmanagementofcovid19inpregnantwomen
AT yangxiao obstetricmanagementofcovid19inpregnantwomen
AT linyonghong obstetricmanagementofcovid19inpregnantwomen